SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K, dated February 25, 2025, serves as a Regulation FD disclosure for National Health Investors Inc. The filing provides supplemental information regarding the quarter ended December 31, 2024. The company is a Maryland corporation listed on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a separate document (Exhibit 99.1) containing the supplemental financial data for the quarter ended December 31, 2024, which is hosted on the company's website.
Material Changes
No material changes versus prior periods are detailed within the text of this Form 8-K. The document acts solely as a notice that supplemental information for the fourth quarter of 2024 has been released.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly directs investors to the supplemental information exhibit for details on the reported period.
Investor Verification Checklist
- Verify the contents of Exhibit 99.1 (Supplemental Information for the quarter ended December 31, 2024) on the company website (www.nhireit.com) to obtain actual financial figures.
- Confirm the specific metrics regarding funds from operations (FFO) or net income for the fourth quarter of 2024 in the referenced exhibit.
- Review the full text of the supplemental release for any updates on occupancy rates, same-store net operating income, or capital expenditure plans not included in this summary.